SINGAPORE – Media OutReach Newswire – 19 October 2026 – A leading Chinese medicine maker told a global gathering of traditional Chinese medicine (TCM) practitioners here Saturday that a 500-year-old tradition built on treating the whole patient and tailoring treatment has offered an Eastern answer to aging societies and chronic disease worldwide.
According to a press report issued by China News Service (CNS), Tianjin Pharmaceutical Da Ren Tang Group, one of China's oldest pharmacy houses, also announced that it would conduct an international randomized, double-blind, controlled trial of its flagship heart remedy, sold in English as Suxiao Jiuxin Pills, in collaboration with Singapore General Hospital, the city-state's largest acute tertiary hospital.
Wang Lei, chairman of Da Ren Tang and president of Tianjin Pharmaceutical Group, made both points in her address at the opening ceremony of the 23rd World Congress of Chinese Medicine in Singapore. She noted that Chinese medicine's holistic approach and pattern-based diagnosis give it an advantage in strengthening public health systems, and that the industry must demonstrate this through internationally recognized, verifiable evidence, the CNS report said.
The study marks the first time a Chinese proprietary medicine has undergone clinical trials at a major Western-medicine hospital in Singapore, the CNS report highlighted.
"We have always believed that Chinese medicine cannot stop at product exports," Wang said, adding that the trial would offer internationally recognized and verifiable clinical evidence.
The congress, hosted by the World Federation of Chinese Medicine Societies and organized by the Singapore Chinese Physicians' Association, ran Oct. 16-18 at Raffles City Convention Centre under the theme "Addressing Global Health Challenges, Integrating Chinese Medicine into National Health Systems." About 1,400 experts, officials and industry representatives from 25 countries and regions participated, the CNS report added.
Wang devoted much of her speech, titled "Gathering the Wisdom of Traditional Medicine to Shoulder the Global Mission of Health," to arguing that traditional medicine belongs in the global public health conversation rather than on its margins.
Chinese medicine's emphasis on the body as a whole, and on tailoring treatment to individual patients' symptom patterns, gives it a distinct advantage in strengthening public health systems, she noted.
For countries facing aging populations and a rising burden of chronic disease, TCM represents "a valuable solution with Eastern characteristics," Wang said, highlighting its contribution to China's "Health Silk Road" vision and its role in China's broader approach to global health governance.
Wang said Da Ren Tang's roughly 70 years of exporting, dating back to 1955, had taught the company that a remedy must suit the actual health needs of the people who take it rather than be shipped abroad merely as a cultural product.
She set out a three-part plan: concentrate clinical research on cardiovascular and cerebrovascular diseases, respiratory conditions, digestive health, musculoskeletal disorders and skin diseases, working with overseas medical institutions to turn traditional experience into evidence regulators can evaluate; follow international research norms while pursuing product registrations and high-quality studies abroad; and recognize that medical systems and regulatory cultures differ from country to country.
"We have to respect the medical systems and cultural contexts of each country and build an open, mutually trusting and mutually beneficial form of cooperation," Wang was quoted as saying by CNS.
According to the CNS report, the company is working with Singapore General Hospital on the study and hopes that solid results will help traditional medicine enter national health systems and reach more patients overseas.
Wang called on the congress to bring Chinese medicine standards into alignment with international rules, build platforms for sharing research results, and tell the story of Chinese medicine to the world.
Da Ren Tang traces its pharmacy lineage to 1522 and has been listed in Singapore since 1997. The company holds 122 exclusive products and 599 drug approval numbers, sells more than 150 products in more than 20 countries, and ranks among China's top five exporters of traditional Chinese medicine, according to the CNS report. Hashtag: #ChinaNewsService
The issuer is solely responsible for the content of this announcement.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
Industry Giants Gather in Ningde to Jointly Accelerate the Layout of the "Tesson Smart Power" Ecosystem
HONG KONG SAR - Media OutReach Newswire - 19 October 2026 - Tesson Holdings Limited (Stock Code: 01201.HK, hereinafter referred to as "Tesson Holdings"), a company listed on the Main Board of The Stock Exchange of Hong Kong Limited, today issued an official announcement stating that its direct wholly-owned subsidiary has entered into an agreement with CCPOM Limited to acquire 100% equity interest in Contemporary Huazhi New Energy Technology Hong Kong Limited (hereinafter referred to as "Contemporary Huazhi (Hong Kong)") for RMB 98.4 million, with a simultaneous capital injection of RMB 21.6 million (representing a total consideration of RMB 120 million).
On the same day, the "Solar-Storage-Charging-Inspection & Intelligent Zero-Carbon" Innovation Seminar and Strategic Signing Ceremony, co-hosted by Times Huazhi (时代华智) and Tesson Holdings, was grandly held at Fujian Jixin Solar-Storage-Charging-Inspection Technology Co., Ltd. (福建集新光储充检技术有限公司) in Overseas Chinese Building, Ningde, Fujian (福建宁德华侨大厦). At the seminar, Mr. Huang Shilin, Co-founder of Contemporary Amperex Technology Co., Limited (hereinafter referred to as "CATL") and Chairman of Fujian Jixin Solar-Storage-Charging-Inspection Technology Co., Ltd. (福建集新光储充检技术有限公司) delivered a keynote speech. He conducted an in-depth analysis of the industry trends regarding the integrated development of new energy and intelligent charging/inspection, which drew enthusiastic responses from the attendees.
The signing ceremony brought together many distinguished guests. Under the joint witness of officiating guests including Mr. Huang Shilin, Professor Yu Changyuan from The Hong Kong Polytechnic University, and Mr. Wei Qingwen, representative of the major shareholder of Tesson Holdings, Tesson Holdings and Times Huazhi (时代华智) officially completed the agreement signing. At the same time, Tesson Holdings joined forces with Times Huazhi (时代华智), Inspur Group, EV Power, Wanji International (万吉国际), and several other industry-leading enterprises as well as top research institutions to sign multiple Memoranda of Understanding (MOUs) for strategic cooperation. This marks a breakthrough achievement for Tesson Holdings in platform-based operations of smart power and new energy infrastructure layout since the launch of its new brand "Tesson Smart Power" in August this year.
Dual Strategy of Acquisition and Capital Injection: Anchoring the Innovative Track of "Solar-Storage-Charging-Inspection and Intelligent Zero-Carbon"
According to the announcement, RMB 38.4 million of the total consideration for this transaction will be paid in cash. The remaining acquisition consideration of RMB 60.0 million will be satisfied and completed by issuing consideration shares at HK$2.00 per share, while the simultaneous capital injection of RMB 21.6 million will be paid and completed as consideration for the subscription shares.
As a pioneer enterprise in the field of intelligent zero-carbon park operations for solar-storage-charging-inspection systems, Times Huazhi (时代华智) has successfully deployed multiple solar-storage-charging-inspection and zero-carbon park projects in core cities such as Shanghai and Fuzhou. Upon completion of this acquisition and capital injection, Tesson Holdings will directly incorporate high-quality new energy infrastructure assets, further enhancing the company's operational capabilities and asset scale in high-power fast charging, energy storage, and zero-carbon microgrids.
Signing of Three Major MOUs: Building a Closed-Loop Chain of "Computing-Power Synergy + Energy-Carbon + Industry-Academia-Research"
At the signing ceremony held on the same day, Tesson Holdings and Times Huazhi (时代华智), together with several industrial partners, reached four deep strategic collaborations:
1. Computing-Power Synergy and Joint Innovation (AIDC): Partnered with Inspur Group and Micro-Gathering Power Sale (微聚售电) to jointly explore the integration model of AI Data Center infrastructure (AIDC) with new power sales and Virtual Power Plants (VPP).
2. Hong Kong Layout and Collaborative Innovation for Solar-Storage-Charging-Inspection: Partnered with EV Power, a leading EV charging operator in Hong Kong, and Wanji International (万吉国际), a green logistics operator, while introducing the 5D Power team from The University of Hong Kong and the HYBAY team from The Hong Kong University of Science and Technology, to jointly create demonstration projects for solar-storage-charging-inspection and green logistics in Hong Kong.
3. Joint Construction of International Innovation Design Center (Hong Kong & Fujian): Partnered with Fuzhou University Design & Research Institute (福州大学设计研究院), Gesuo Technology (格索科技), and Anlaseo (a spin-off enterprise from The Hong Kong Polytechnic University) to promote the engineering applications of achievements such as smart energy replenishment stations for solar-storage-charging-inspection.
Tesson Holdings and Times Huazhi (时代华智) deepened their cooperation by leveraging the advantages of the global industrial chain ecosystem resources of CATL to jointly explore the strategic collaborations implementation and innovative industrial upgrading of securitization for energy-carbon assets in new power track of solar-storage-charging-inspection.
Management of Tesson Holdings stated that the completion of this acquisition and multi-party strategic cooperation marks a crucial step for the company toward becoming an "Innovative Operator in Smart Power and Energy-Carbon". Looking ahead, Tesson Holdings will rely on its development roadmap of "Battery Manufacturing — Zero-Carbon Microgrid & Energy Storage Operations — AI Power Trading & Energy-Carbon Asset Platform", and fully utilize the strong support and resource empowerment from strategic shareholder Mr. Huang Shilin, Co-founder of CATL. The company will continue to deepen its green energy network layout in the Greater Bay Area and core cities, creating long-term value for urban low-carbon transformation.
Hashtag: #TessonHoldings
The issuer is solely responsible for the content of this announcement.
About Tesson Holdings Limited (1201.HK)
Tesson Holdings Limited (Stock Code: 01201.HK) is a company listed on the Main Board of The Stock Exchange of Hong Kong Limited, focusing on (among other things) the deep integration of the new energy industry chain. Its strategic positioning includes being an innovative operator in smart power and energy-carbon. Centering on "Smart Power Source + Smart Electricity", the company comprehensively expands into energy storage, solar-storage-charging-inspection, zero-carbon microgrids, AI energy management, and energy-carbon asset operations, striving to connect global high-quality industrial and capital resources to empower the high-quality development of the new energy ecosystem.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
